Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Erik Ostrowski

CFO at Akebia Therapeutics, Inc. (AKBA)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $111K

Reported trades

Filed Stock Type Shares Price Value Since
Jul 1SEC AKBAAkebia Therapeutics, Inc. Sell Plan 56,019616,616 held (−8%) $1.11 $62K -39.6%
Feb 4SEC AKBAAkebia Therapeutics, Inc. Sell Plan 34,951672,635 held (−5%) $1.39 $49K -51.8%
  • Sell

    CFO Erik Ostrowski sold $62K of AKBA at $1.11 — pre-scheduled 10b5-1 plan sale.

  • Sell

    CFO Erik Ostrowski sold $49K of AKBA at $1.39 — pre-scheduled 10b5-1 plan sale.